Federation des caisses Desjardins du Quebec boosted its stake in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 18.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,120 shares of the company's stock after purchasing an additional 2,846 shares during the period. Federation des caisses Desjardins du Quebec's holdings in HCA Healthcare were worth $6,262,000 at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the business. First Manhattan CO. LLC. raised its stake in shares of HCA Healthcare by 32.3% during the first quarter. First Manhattan CO. LLC. now owns 16,166 shares of the company's stock valued at $5,586,000 after acquiring an additional 3,951 shares during the last quarter. Paloma Partners Management Co bought a new position in shares of HCA Healthcare during the first quarter valued at $394,000. Focus Partners Advisor Solutions LLC raised its stake in shares of HCA Healthcare by 39.0% during the first quarter. Focus Partners Advisor Solutions LLC now owns 1,409 shares of the company's stock valued at $487,000 after acquiring an additional 395 shares during the last quarter. MAI Capital Management raised its stake in HCA Healthcare by 2.6% during the first quarter. MAI Capital Management now owns 2,581 shares of the company's stock worth $892,000 after buying an additional 66 shares during the last quarter. Finally, Quarry LP raised its stake in HCA Healthcare by 27.6% during the first quarter. Quarry LP now owns 1,132 shares of the company's stock worth $391,000 after buying an additional 245 shares during the last quarter. Institutional investors own 62.73% of the company's stock.
Analyst Ratings Changes
HCA has been the subject of a number of analyst reports. Stephens raised shares of HCA Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Royal Bank Of Canada lowered their target price on shares of HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a research note on Monday, July 28th. Wolfe Research downgraded shares of HCA Healthcare from an "outperform" rating to a "peer perform" rating in a research note on Monday, July 28th. Morgan Stanley decreased their price target on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating for the company in a research note on Monday, July 28th. Finally, Barclays decreased their price target on shares of HCA Healthcare from $416.00 to $390.00 and set an "overweight" rating for the company in a research note on Monday, July 28th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus price target of $401.83.
View Our Latest Stock Report on HCA Healthcare
HCA Healthcare Stock Up 2.2%
HCA stock traded up $9.09 during trading on Friday, reaching $420.68. The stock had a trading volume of 1,059,770 shares, compared to its average volume of 1,054,336. HCA Healthcare, Inc. has a one year low of $289.98 and a one year high of $420.98. The company has a quick ratio of 0.86, a current ratio of 0.98 and a debt-to-equity ratio of 69.07. The company's 50 day moving average is $380.14 and its two-hundred day moving average is $360.12. The company has a market capitalization of $98.43 billion, a price-to-earnings ratio of 17.68, a P/E/G ratio of 1.32 and a beta of 1.41.
HCA Healthcare (NYSE:HCA - Get Free Report) last released its earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, beating analysts' consensus estimates of $6.20 by $0.64. The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company's revenue was up 6.4% compared to the same quarter last year. During the same period in the prior year, the firm earned $5.50 EPS. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. Equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.
HCA Healthcare Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, September 16th. HCA Healthcare's dividend payout ratio (DPR) is presently 12.11%.
HCA Healthcare Profile
(
Free Report)
HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.
See Also

Before you consider HCA Healthcare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCA Healthcare wasn't on the list.
While HCA Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.